Lansoprazole Drug Interactions
26Total Interactions
8Severe
16Moderate
1Mild
| Drug | Severity | Summary |
|---|---|---|
| Atazanavir | SEVERE | Lansoprazole decreases the exposure to Atazanavir. Manufacturer advises avoid or adjust dose. |
| Belumosudil | SEVERE | Lansoprazole is predicted to decrease the exposure to Belumosudil. Manufacturer advises adjust Be... |
| Dasatinib | SEVERE | Lansoprazole is predicted to decrease the exposure to Dasatinib. Manufacturer advises avoid. |
| Gefitinib | SEVERE | Lansoprazole is predicted to decrease the exposure to Gefitinib. Manufacturer advises caution. |
| Methotrexate | SEVERE | Lansoprazole decreases the clearance of Methotrexate (high-dose). Manufacturer advises use with c... |
| Neratinib | SEVERE | Lansoprazole is predicted to decrease the exposure to Neratinib. Manufacturer advises avoid. |
| Pemigatinib | SEVERE | Lansoprazole has been reported to decrease the exposure to Pemigatinib. Manufacturer advises avoid. |
| Rilpivirine | SEVERE | Lansoprazole is predicted to decrease the exposure to oral Rilpivirine. Manufacturer advises avoid. |
| Bosutinib | MODERATE | Lansoprazole is predicted to decrease the absorption of Bosutinib. Manufacturer advises caution. |
| Ceritinib | MODERATE | Lansoprazole is predicted to decrease the absorption of Ceritinib. Manufacturer makes no recommen... |
| Dacomitinib | MODERATE | Lansoprazole is predicted to decrease the exposure to Dacomitinib. Manufacturer advises avoid. |
| Dipyridamole | MODERATE | Lansoprazole is predicted to decrease the absorption of Dipyridamole (immediate release tablets).... |
| Erlotinib | MODERATE | Lansoprazole is predicted to decrease the exposure to Erlotinib. Manufacturer advises avoid. |
| Itraconazole | MODERATE | Lansoprazole decreases the absorption of Itraconazole. Manufacturer advises administer itraconazo... |
| Ketoconazole | MODERATE | Lansoprazole decreases the absorption of Ketoconazole. Manufacturer advises administer ketoconazo... |
| Ledipasvir | MODERATE | Lansoprazole is predicted to decrease the exposure to Ledipasvir. Manufacturer advises adjust dos... |
| Pazopanib | MODERATE | Lansoprazole is predicted to decrease the exposure to Pazopanib. Manufacturer advises avoid or ad... |
| Posaconazole | MODERATE | Lansoprazole decreases the absorption of Posaconazole oral suspension. Manufacturer advises avoid. |
| Selpercatinib | MODERATE | Lansoprazole is predicted to decrease the exposure to Selpercatinib. Manufacturer advises take wi... |
| Sofosbuvir | MODERATE | Lansoprazole potentially decreases the exposure to Sofosbuvir. Manufacturer advises adjust dose, ... |
| Sotorasib | MODERATE | Lansoprazole is predicted to decrease the exposure to Sotorasib. Manufacturer advises give Sotora... |
| Sparsentan | MODERATE | Sparsentan is predicted to decrease the exposure to Lansoprazole. Manufacturer advises caution. |
| Velpatasvir | MODERATE | Lansoprazole is predicted to decrease the concentration of Velpatasvir. Manufacturer advises adju... |
| Voxilaprevir | MODERATE | Lansoprazole is predicted to decrease the exposure to Voxilaprevir. Manufacturer advises adjust d... |
| Apalutamide | MILD | Apalutamide is predicted to decrease the exposure to Lansoprazole. Manufacturer advises avoid or ... |
| Ulipristal | UNKNOWN | Lansoprazole might decrease the efficacy of Ulipristal for emergency hormonal contraception. For ... |
Check Lansoprazole against your patient's full medication list
InteractRx checks all drug combinations at once — built for GP surgery pharmacists.
Use the Free Checker